SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-240544
Filing Date
2020-09-08
Accepted
2020-09-08 07:40:54
Documents
12
Period of Report
2020-09-08

Document Format Files

Seq Description Document Type Size
1 6-K d45816d6k.htm 6-K 20633
2 EX-1.1 d45816dex11.htm EX-1.1 257926
3 EX-4.1 d45816dex41.htm EX-4.1 94458
4 EX-4.2 d45816dex42.htm EX-4.2 95693
5 EX-4.3 d45816dex43.htm EX-4.3 91226
6 EX-5.1 d45816dex51.htm EX-5.1 41561
7 EX-5.2 d45816dex52.htm EX-5.2 13787
8 EX-10.1 d45816dex101.htm EX-10.1 23042
9 EX-99.1 d45816dex991.htm EX-99.1 11892
10 GRAPHIC g45816g0904115424635.jpg GRAPHIC 2939
11 GRAPHIC g45816g0907212211608.jpg GRAPHIC 2754
12 GRAPHIC g45816g0907213613978.jpg GRAPHIC 2403
  Complete submission text file 0001193125-20-240544.txt   662830
Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Filer) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37993 | Film No.: 201162965
SIC: 2834 Pharmaceutical Preparations